CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)
Julian K. Horwitz, Fady M. Kaldas – 1 September 2022
Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40
Branden D. Tarlow, W. Ray Kim, Ajitha Mannalithara, Paul Y. Kwo, C. Andrew Bonham, Allison Kwong – 1 September 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Bolni Marius Nagalo, Yumei Zhou, Emilien J. Loeuillard, Chelsae Dumbauld, Oumar Barro, Natalie M. Elliott, Alexander T. Baker, Mansi Arora, James M. Bogenberger, Nathalie Meurice, Joachim Petit, Pedro Luiz Serrano Uson, Faaiq Aslam, Elizabeth Raupach, Musa Gabere, Alexei Basnakian, Camila C. Simoes, Martin J. Cannon, Steven R. Post, Kenneth Buetow, Jean Christopher Chamcheu, Michael T. Barrett, Dan G. Duda, Bertram Jacobs, Richard Vile, Michael A. Barry, Lewis R. Roberts, Sumera Ilyas, Mitesh J. Borad – 1 September 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
Willemien Zwol, Antoine Rimbert, Justina C. Wolters, Marieke Smit, Vincent W. Bloks, Niels J. Kloosterhuis, Nicolette C. A. Huijkman, Mirjam H. Koster, Umesh Tharehalli, Simon M. Neck, Colin Bournez, Marceline M. Fuh, Jeroen Kuipers, Sujith Rajan, Alain Bruin, Henry N. Ginsberg, Gerard J. P. Westen, M. Mahmood Hussain, Ludger Scheja, Joerg Heeren, Philip Zimmerman, Bart Sluis, Jan Albert Kuivenhoven – 1 September 2022
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)
Julian K. Horwitz, Fady M. Kaldas – 1 September 2022
Letter to the editor: In utero exposure to mercury is associated with increased susceptibility to liver injury and inflammation in childhood
Muhammad Zawar Asif, Muhammad Umair, Muhammad Shehryar – 31 August 2022
Mycophenolate mofetil discontinuation increases severe acute respiratory syndrome coronavirus 2 vaccine response in nonresponder liver transplantation recipients: A proof of concept
Lucy Meunier, Emilie Malezieux, José Ursic Bedoya, Stéphanie Faure, Maxime Echenne, Antoine Debourdeau, Magdalena Meszaros, Georges Philippe Pageaux – 31 August 2022
Drug, Herbal, and Dietary Supplement–induced Liver Injury
The aim of this practice guidance is to provide recommendations regarding the common clinical, laboratory, and histological features seen in patients with DILI based on observational and epidemiological data reported in case series or DILI registries.
Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Shigeru Mikami, Uojima Haruki, Keiichiro Yoshikata, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa‐Iwashita, Norio Itokawa, Chisa Kondo, Keiko Kaneko, Mototsugu Nagao, Kyoko Inagaki, Izumi Fukuda, Hitoshi Sugihara, Katsuhiko Iwakiri – 29 August 2022 – The aim of this retrospective multicenter study was to clarify the antifibrotic effect and long‐term outcome of sodium glucose cotransporter 2 inhibitors (SGLT2‐Is) in patients with nonalcoholic fatty liver disease (NAFLD) complicated by t
Erratum
29 August 2022